Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05044273 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

Study acronym: IRIS SynergyXD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site contacts updated at 2 of 23 sitesv10
  2. Study sites: 21 to 23v9
  3. Primary completion date: Dec 31, 2024 to Dec 31, 2026 Completion date: Dec 31, 2028 to Dec 31, 2031 · Site details revised at 20 of 21 sitesv8 Show 2 more changesShow less
    • Completion date: Dec 31, 2028 to Dec 31, 2031
    • Site details revised at 20 of 21 sites
  4. Enrollment target: 1000 to 2000 Site contacts updated at 20 of 21 sitesv7 Show 1 more changeShow less
    • Site contacts updated at 20 of 21 sites
  5. Study sites: 16 to 21v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Study sites: 1 to 16 · Start date changed from estimate of Aug 15, 2022 to Sep 1, 2022v5 Show 2 more changesShow less
    • Study sites: 1 to 16
    • Start date changed from estimate of Aug 15, 2022 to Sep 1, 2022
  2. Start date: Jun 30, 2022 to Aug 15, 2022 Interventions: Synergy XD stent (Device) to Synergy XD stent or Synergy Megatron™ Stent (Device) · Eligibility criteria expanded, about 4 words · Study description expanded, about 4 words · 1 morev4 Show 4 more changesShow less
    • Interventions: Synergy XD stent (Device) to Synergy XD stent or Synergy Megatron™ Stent (Device)
    • Eligibility criteria expanded, about 4 words
    • Study description expanded, about 4 words
    • Study title expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Start date: Oct 31, 2021 to Jun 30, 2022v3
  4. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.
Trial Details
NCT Number NCT05044273
Lead Sponsor Jung-min Ahn
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases, Myocardial Ischemia, Coronary Disease
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov